Adar Poonawalla, CEO of Serum Institute of India, highlighted the potential of the vaccine to save lives in malaria-stricken regions of Africa and acknowledged ... Oct 04
Adar Poonawalla says WHO approval expected in next couple of weeks... Jan 15
Adar Poonawalla said the vaccine will be priced at a maximum of Rs 1,000 for two necessary doses for the public, depending on the ... Nov 20
Serum Institute Chief clarified about India trial... Sep 10
The objective of this trial is to evaluate the ability of VPM1002 in reducing infection incidence and severe disease outcomes of COVID-19 among high-... Jul 27
-Advertisements-